Cargando…
Pathogenic NF1 truncating mutation and copy number alterations in a dedifferentiated liposarcoma with multiple lung metastasis: a case report
BACKGROUND: Dedifferentiated liposarcoma (DDLPS), which accounts for an estimated 15–20% of liposarcomas, is a high-grade and aggressive malignant neoplasm, exhibiting a poor response to available therapeutic agents. However, genetic alteration profiles of DDLPS as well as the role of NF1 mutations...
Autores principales: | Kim, Yoon-Seob, Shin, Sun, Jung, Seung-Hyun, Chung, Yeun-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552537/ https://www.ncbi.nlm.nih.gov/pubmed/33046013 http://dx.doi.org/10.1186/s12881-020-01137-4 |
Ejemplares similares
-
Retroperitoneal dedifferentiated liposarcoma with osteosarcomatous dedifferentiation
por: Nguyen, Vinh N., et al.
Publicado: (2015) -
Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcoma
por: Jagosky, Megan H., et al.
Publicado: (2022) -
Adipogenesis induces growth inhibition of dedifferentiated liposarcoma
por: Kim, Yu Jin, et al.
Publicado: (2019) -
Spinal Metastasis of Well-Differentiated Liposarcoma Component in Retroperitoneal Dedifferentiated Liposarcoma Treated by Minimally Invasive Surgery
por: Ichikawa, Jiro, et al.
Publicado: (2018) -
Myogenic dedifferentiation is associated with poor outcomes in retroperitoneal dedifferentiated liposarcomas
por: Dorian Yarih, Garcia-Ortega, et al.
Publicado: (2021)